Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Actinogen Medical ( (AU:ACW) ) is now available.
Actinogen Medical Limited has applied to the ASX for quotation of 218,449 new ordinary fully paid shares, to be listed under its existing ticker ACW. The additional securities, issued on 19 December 2025 following the exercise or conversion of existing instruments, will modestly expand the company’s free float and may incrementally enhance liquidity for shareholders without indicating any broader strategic shift in operations.
The most recent analyst rating on (AU:ACW) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Actinogen Medical stock, see the AU:ACW Stock Forecast page.
More about Actinogen Medical
Actinogen Medical Limited is an Australian biotechnology company listed on the ASX under the code ACW. It operates in the medical and biopharmaceutical sector, focusing on the development of therapeutic products, with its securities traded on the Australian equities market.
Average Trading Volume: 4,281,688
Technical Sentiment Signal: Buy
Current Market Cap: A$175M
For an in-depth examination of ACW stock, go to TipRanks’ Overview page.